The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - EUSA Pharma; Jazz Pharmaceuticals
The randomised induction for high-risk neuroblastoma comparing COJEC and N5-MSKCC regimens: Early results from the HR-NBL1.5/SIOPEN trial.
 
Alberto Garaventa
No Relationships to Disclose
 
Ulrike Poetschger
No Relationships to Disclose
 
Dominique Valteau-Couanet
No Relationships to Disclose
 
Victoria Castel
No Relationships to Disclose
 
Martin Elliott
No Relationships to Disclose
 
Shifra Ash
No Relationships to Disclose
 
Godfrey Chi-Fung Chan
Speakers' Bureau - Apotex; China Regenerative Medicine
Patents, Royalties, Other Intellectual Property - HKU
Travel, Accommodations, Expenses - Apotex
 
Genevieve Laureys
No Relationships to Disclose
 
Maja Beck Popovic
No Relationships to Disclose
 
Kim Vettenranta
No Relationships to Disclose
 
Walentyna Balwierz
Travel, Accommodations, Expenses - Astellas Medivation; Shire
 
Henrik Schroeder
No Relationships to Disclose
 
Cormac Owens
No Relationships to Disclose
 
Maja Cesen
No Relationships to Disclose
 
Vassilios Papadakis
Travel, Accommodations, Expenses - Astellas Pharma; MSD; Sanofi
 
Toby Trahair
Stock and Other Ownership Interests - CSL Limited; Pfizer
 
Roberto Luksch
No Relationships to Disclose
 
Gudrun Schleiermacher
No Relationships to Disclose
 
Peter F Ambros
No Relationships to Disclose
 
Ruth Lydia Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma
Consulting or Advisory Role - Apeiron Biologics; Boehringer Ingelheim; EUSA Pharma (Inst)
Research Funding - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst); EUSA Pharma (Inst)
Expert Testimony - Apeiron Biologics
Travel, Accommodations, Expenses - Apeiron Biologics; EUSA Pharma